U.S. flag

An official website of the United States government

NM_000156.6(GAMT):c.17C>T (p.Ala6Val) AND Deficiency of guanidinoacetate methyltransferase

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 7, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001828001.1

Allele description [Variation Report for NM_000156.6(GAMT):c.17C>T (p.Ala6Val)]

NM_000156.6(GAMT):c.17C>T (p.Ala6Val)

Genes:
LOC130062945:ATAC-STARR-seq lymphoblastoid silent region 9707 [Gene]
GAMT:guanidinoacetate N-methyltransferase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.3
Genomic location:
Preferred name:
NM_000156.6(GAMT):c.17C>T (p.Ala6Val)
Other names:
p.A6V:GCG>GTG
HGVS:
  • NC_000019.10:g.1401460G>A
  • NG_009785.1:g.5094C>T
  • NM_000156.6:c.17C>TMANE SELECT
  • NM_138924.3:c.17C>T
  • NP_000147.1:p.Ala6Val
  • NP_620279.1:p.Ala6Val
  • NC_000019.9:g.1401459G>A
  • NM_000156.4:c.17C>T
  • NM_000156.5:c.17C>T
Protein change:
A6V
Links:
dbSNP: rs796052529
NCBI 1000 Genomes Browser:
rs796052529
Molecular consequence:
  • NM_000156.6:c.17C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_138924.3:c.17C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Deficiency of guanidinoacetate methyltransferase (CCDS2)
Synonyms:
CEREBRAL CREATINE DEFICIENCY SYNDROME 2
Identifiers:
MONDO: MONDO:0012999; MedGen: C0574080; Orphanet: 382; OMIM: 612736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002087067Natera, Inc.
no assertion criteria provided
Uncertain significance
(Mar 7, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002087067.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024